The University of Chicago Header Logo

Connection

Aaron Esser-Kahn to Adjuvants, Pharmaceutic

Back to Details
This is a "connection" page, showing publications Aaron Esser-Kahn has written about Adjuvants, Pharmaceutic.
Aaron Esser-Kahn
Connection Strength
0.054
Adjuvants, Pharmaceutic
  1. Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants. Sci Rep. 2022 06 02; 12(1):9198.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.